Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
NCT03577665 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-08-21
Summary
Proton alone therapy is performed
-\> 5 times a week, 7200 cGy / 15 fractions for 3 weeks total
Conditions
Interventions
- RADIATION
-
curative proton therapy
Patients who meet the selection criteria are selected, signed for consent, and treated with proton therapy alone at 7200 cGy / 15 fractions, 5 times a week for 3 weeks
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
Dae Yong Kim, M.D. · National Cancer Center Korea(South Korea)
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-21
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
NCT06665087 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
NCT06601075 ·Status: RECRUITING
-
Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma
NCT05173610 ·Status: UNKNOWN ·Phase: PHASE2
-
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer
NCT03098108 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
NCT01847495 ·Status: WITHDRAWN ·Phase: NA
-
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
NCT03135652 ·Status: WITHDRAWN ·Phase: PHASE2
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.
NCT03963726 ·Status: UNKNOWN ·Phase: NA
-
Radioembolization in Elderly/ Fragile Patients With mCRC
NCT05092880 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT01651026 ·Status: UNKNOWN
-
Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT07258797 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
NCT03654131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer
NCT02909114 ·Status: UNKNOWN ·Phase: PHASE2
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
NCT05807984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
NCT07247396 ·Status: RECRUITING ·Phase: PHASE1
-
Intraoperative Radiation Therapy for Resectable Pancreatic Cancer
NCT03273374 ·Status: COMPLETED ·Phase: NA
-
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
NCT07333651 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.
NCT06160570 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
NCT07343791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Short-course Preoperative Chemoradiotherapy for Rectal Cancer
NCT01431599 ·Status: UNKNOWN ·Phase: PHASE2